Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5783_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Acknowledgments
- •Contents
- •Contributors
- •1.2 How Is Critical Care Humanized?
- •References
- •2.1 Introduction
- •1.2.2 Communication
- •1.2.5 Post-ICU Syndrome
- •1.2.6 Humanized Infrastructure
- •1.2.7 End-of-Life Care
- •2.2 Which Patients Should Undergo ICP Monitoring?
- •2.5.2.3 CSF Drainage
- •2.5.2.4 Osmotherapy
- •2.5.2.5 Ventilation
- •2.5.2.6 CPP Augmentation
- •2.5.2.7 Metabolic Suppression
- •2.5.2.8 Pharmacologic Suppression
- •2.5.2.9 Temperature Modulation
- •2.5.2.10 Decompressive Craniectomy
- •2.7.1.1 Pressure Reactivity Index (PRx)
- •2.7.1.2 Multimodality Monitoring
- •2.8 Conclusion
- •Algorithm
- •References
- •3.1 Introduction
- •3.2 Intracerebral Hemorrhage (ICH)
- •3.3 ICH: Presenting Symptoms
- •3.5.1 Blood Hypertension
- •3.5.2 Other Risk Factors
- •3.6 ICH: Pathophysiology
- •3.7 ICH: Initial Management
- •3.7.1 Airway: Intubation
- •3.7.3 ICH: Imaging
- •3.7.4 ICH: Grading Scales
- •3.7.5 Fluid Management
- •3.7.6 Follow-Up Imaging
- •3.7.7 Blood Pressure Management
- •3.7.9 ICP Monitoring
- •3.7.10 Surgical Considerations
- •3.7.13 ICH: Venous Thromboembolism Prophylaxis
- •3.7.14 ICH: Seizure Management
- •3.8 ICH: Medical Complications
- •3.8.1 Glycemic Management
- •3.8.3 Disposition
- •3.9 Conclusion
- •Algorithm
- •Appendix: Direct Oral Anticoagulant Reversal
- •Reversal Strategies
- •References
- •4.1 Introduction
- •4.2.1 Hemodynamic Management
- •4.2.2 Hormonal Replacement Therapy
- •4.2.3 Respiratory Management
- •4.3 Cardiopulmonary Resuscitation (CPR)
- •4.4 Conclusion
- •Algorithm
- •References
- •5.1 Introduction
- •5.2.1 Vasoactive Agents
- •5.2.1.1 Vasodilators (Table 5.1)
- •Calcium Channel Blockers
- •Nimodipine
- •Nicardipine
- •Other Vasodilators
- •Magnesium
- •3-Hydroxy-3-Methyl-Glutaryl-CoA (HMG-CoA) Reductase Inhibitors (Statins)
- •Nitroprusside
- •Endothelin-1 Antagonists
- •Hydralazine
- •Phosphodiesterase Inhibitors
- •Papaverine
- •Norepinephrine
- •Epinephrine
- •Dopamine (DA)
- •Phenylephrine
- •Vasopressin
- •Neuromonitoring
- •5.2.2.1 Benzodiazepines
- •5.2.2.2 Barbiturates
- •5.2.2.3 Opioids
- •5.2.2.4 Anticonvulsant Medications
- •5.2.2.5 Other Sedatives/Anesthetics
- •5.2.3 Hemodynamic Agents
- •5.4 Conclusion
- •Algorithm
- •References
- •6.1 Introduction
- •6.2.3 Ultrasound Behaviour at Acoustic Boundaries
- •6.3 Pulse-Echo Principles (B-Mode Techniques)
- •6.4 Transducers
- •6.5 Artefacts
- •6.6 Doppler Principles
- •6.6.1 Pulsed Wave Doppler
- •6.6.2 Duplex Scanning
- •6.6.3 Colour Flow Imaging (CFI)
- •6.7.2 Flow Changes
- •6.7.3 Cerebrovascular Resistance
- •6.8 Transcranial Colour-Coded Duplex Sonography (TCCS)
- •6.9 Ultrasound Safety
- •6.10 Conclusion
- •References
- •7.1 Introduction
- •Mesencephalic Plane
- •7.2.1.2 Diencephalic Plane (Thalamic Plane)
- •6.6.4 Power Doppler Imaging (PDI)
- •6.7 Transcranial Doppler Ultrasound (TCD)
- •6.7.1 Velocity Measurement
- •7.2.1.3 Ventricular Plane (Cella Media)
- •7.2.1.4 Upper Pons Plane
- •7.2.1.5 Lower Pons Plane
- •7.2.2 Transforaminal Window
- •7.3.1.2 Anterior Circulation
- •Carotid System
- •Anterior Cerebral Artery
- •Anterior Communicating Antery
- •7.3.1.3 Posterior Circulation
- •Vertebrobasilar System
- •Posterior Communicating Artery
- •Posterior Cerebral Arteries
- •7.5 Cerebral Circulation: Anatomical Variations
- •7.5.1.1 Anterior Circulation
- •Most Common Variations [28]
- •7.5.1.2 Posterior Circulation
- •Most Common Variants [28]
- •7.6.1.1 Deep Middle Cerebral Vein (DMCV)
- •7.6.1.2 Basal Vein (of Rosenthal)
- •7.6.1.3 Great Cerebral Vein (of Galen)
- •7.6.2.1 Sphenoparietal Sinus
- •7.6.2.2 Superior Petrosal Sinus
- •7.6.2.3 Inferior Petrosal Sinus
- •7.6.2.4 Cavernous Sinus
- •7.6.2.5 Transverse Sinus
- •7.6.2.6 Straight Sinus
- •7.7 Conclusion
- •Algorithm
- •References
- •8.1 Introduction
- •8.2 Cerebral Blood Flow Measures
- •8.3 Transcranial Doppler (TCD/TCCS)
- •8.4.1 Cerebral Autoregulation (CA)
- •8.4.2 CO2 Vasoreactivity
- •8.6.2 TCD/TCCS: Use After Traumatic Brain Injury (TBI)
- •8.7 Conclusion
- •References
- •9.1 Introduction
- •9.3 TCD Hemodynamic Parameters: Variations by Sex
- •9.4 TCD Hemodynamic Parameters: Variations by Age
- •9.5 TCD Hemodynamic Parameters: Variations by Laterally
- •9.7 TCD Normal Values: Latin American Population Sample
- •9.8 TCD Hemodynamic Parameters: Altitude
- •9.10 Conclusion
- •References
- •10.1 Introduction
- •10.2 TCD/TCCS: Acoustic Windows
- •10.2.1.1 Technique
- •10.2.2.1 Technique
- •10.2.3.1 Technique
- •10.2.4.1 Technique
- •10.2.5.1 Technique
- •10.4.1 Decompressive Craniectomy
- •10.4.2 Patient’s Position
- •10.5 TCD/TCCS: Contrast-Enhanced
- •10.6 Conclusion
- •Algorithm
- •References
- •11.1 Introduction
- •11.2 Basic Methods
- •11.2.1 Flow Velocities
- •11.2.2 Pulsatility Index (PI)
- •11.3 Advanced Methods
- •11.3.2 TAU (Cerebrovascular Time Constant)
- •11.3.4 Autoregulation
- •11.4.1 Traumatic Brain Injury
- •11.4.2 Aneurysmal Subarachnoid Hemorrhage
- •11.4.3 Stroke
- •11.4.4 Other Clinical Scenarios
- •11.5 Conclusion
- •Algorithm
- •References
- •12.1 Introduction
- •12.2 TCD: Spectral Wave
- •12.4 TCD: Clinical Utility
- •12.6 TCD: Technique
- •12.6.2 Transtemporal Acoustic Window
- •12.6.2.1 Anterior Circulation
- •Middle Cerebral Artery (MCA)
- •12.6.2.2 Posterior Circulation
- •Posterior Cerebral Artery (PCA)
- •12.6.3 Submandibular Acoustic Window
- •12.6.3.1 Internal Carotid Artery (ICA—Extracranial Portion)
- •12.6.4 Transoccipital Acoustic Window
- •12.6.4.1 Posterior Circulation
- •12.6.5 Transorbital Acoustic Window
- •12.6.6.2 Pulsatility Index
- •12.7.1 High-Velocity Pattern
- •12.7.2 Low-Velocity Pattern
- •12.7.3 High Resistance Pattern
- •12.7.4 Cerebral Circulatory Arrest Pattern
- •12.8 TCD: Other Clinical Uses
- •12.8.1.1 Cerebral Vascular Reactivity
- •12.9 TCD: Limitations
- •12.10 Conclusion
- •Algorithm
- •References
- •13.1 Introduction
- •13.2 Acoustic Windows
- •13.3 2D-Guided TCD Monitoring
- •13.6 Conclusion
- •Algorithm
- •References
- •14.1 Introduction
- •14.2 TCCS: Anatomical Aspects
- •14.3.1 Anterior Circulation
- •14.3.1.1 Carotid System
- •14.3.2 Posterior Circulation
- •14.3.2.1 Vertebro-Basilar System
- •14.5 TCCS: Examiner Considerations
- •14.6 TCCS: Acoustic Windows
- •14.7 TCCS: Examination Protocol
- •14.7.1.1 Considerations
- •Doppler: (Convention)
- •14.7.2 Transtemporal Acoustic Window Examination (Coronal Planes)
- •14.7.3 Transoccipital (Transnuchal/Transforaminal) Acoustic Window Examination
- •14.7.4 Submandibular Acoustic Window Examination
- •14.7.5 Transorbital Acoustic Window Examination
- •14.7.6 Frontal Bone Window Examination
- •14.8 TCCS Protocol: Clinical Applications
- •14.9 TCCS Protocol: Hemodynamic Parameters
- •14.10 TCCS Protocol: Limitations
- •14.10.1 Limitations
- •14.10.1.1 Acoustic Windows
- •Transtemporal Acoustic Window
- •Suboccipital Acoustic Window
- •14.10.1.2 Middle-Line Shift Measurement
- •14.11 Conclusion
- •Algorithm
- •References
- •15.1 Introduction
- •15.2 Clinical Applications
- •15.2.1 Intracranial Stenosis
- •15.2.2 Cerebral Vasospasm
- •15.2.3 Cerebral Veins
- •15.3 Conclusion
- •References
- •16.1 Introduction
- •16.3.1 Autoregulation Index (ARI)
- •16.3.2 Mean Flow Velocity Index (Mx)
- •16.5 Conclusion
- •References
- •17.1 Introduction
- •17.2.1 Cerebrovascular Resistance (CVR)
- •17.2.2 Cerebral Autoregulation
- •17.2.4 Carbon Dioxide Reactivity
- •17.3.2 Collateral Flow
- •17.3.3 Elastic Reservoir (“Windkessel Effect”)
- •17.4 TCD: Waveform Interpretation
- •17.4.1 TCD Waveforms
- •17.5.1 Aneurysmal Subarachnoid Hemorrhage
- •17.5.2 Increased ICP
- •17.6 Conclusion
- •References
- •18.1 Introduction
- •18.3.1 Subarachnoid Hemorrhage (SAH)
- •18.3.1.1 Cerebral Autoregulation (CA)
- •18.3.1.2 Intraparenchymal Cerebral Oxygen Monitoring
- •18.3.1.3 Cerebral Blood Flow
- •18.3.1.4 Electrophysiology
- •Seizure Detection
- •18.3.1.5 Cerebral Metabolism
- •18.3.2 Intracerebral Hemorrhage (ICH)
- •18.3.2.1 Intraparenchymal Cerebral Oxygen Monitoring
- •18.3.2.3 Electrophysiology
- •18.3.3 Traumatic Brain Injury (TBI)
- •18.3.3.2 Cerebral Autoregulation
- •18.3.3.3 Intraparenchymal Cerebral Oxygen Monitoring
- •18.3.3.4 Cerebral Blood Flow
- •18.3.3.5 Electrophysiology
- •18.3.3.6 Cerebral Metabolism
- •18.3.4 Acute Ischemic Stroke (AIS)
- •18.3.4.1 Cerebral Blood Flow
- •18.3.4.2 Electrophysiology
- •18.3.5.1 Cerebral Blood Flow
- •18.4 Conclusion
- •References
- •19.1 Introduction
- •19.2 Cerebral Blood Haemodynamic Measurements
- •19.3 Cerebral Blood Flow (CBF): Physiology Principles
- •19.4 Vasoreactivity Determining: Methods
- •19.6 Technical Tips
- •19.7 Vasoreactivity: Clinical Importance
- •19.8 Conclusion
- •References
- •20.1 Introduction
- •20.5.4.1 Experimental Endotoxemia
- •20.6 Conclusion
- •Appendix
- •Methods
- •Group 1: Graphic Methods
- •“Beat-by-Beat Method”
- •Method Described by Aaslid
- •Group 2: Multiparameter or Impedance Methods [14]
- •References
- •21.1 Introduction
- •21.2.1 Brain Compliance
- •21.2.2 TCD/TCCS: Cerebral Hemodynamics
- •21.4 Pulsatility Index (PI): Intracranial Pressure (ICP)
- •21.5.1 Cardiovascular Factors
- •21.5.2 Cerebrovascular Factors
- •21.5.3 Cardiopulmonary Factors
- •21.5.4 Metabolism Factors
- •21.5.5 Vascular Factors
- •21.5.6 Other Factors
- •21.6 Conclusion
- •Algorithm
- •References
- •22.1 Introduction
- •22.2 Aneurysmal Subarachnoid Hemorrhage (aSAH)
- •22.3 Cerebral Vasospasm After aSAH
- •22.5.1 TCD/TCCS: Examination Protocol
- •22.5.1.1 Transtemporal Window
- •22.5.1.2 Orbital Window
- •22.5.1.3 Suboccipital/Transforaminal Window
- •22.5.1.4 Submandibular Window
- •22.7 Conclusion
- •Algorithm
- •References
- •23.1 Introduction
- •23.3.1 Premise
- •23.3.3 Limitations
- •23.4.1 Technical Requirements
- •23.4.3 Limitations
- •23.6 Future Directions
- •23.7 Conclusion
- •Algorithm
- •References
- •24.1 Introduction
- •24.2.1 Vasospasm
- •24.2.2 Vasospasm Diagnostic Criteria
- •24.3 TCD/TCCS: Cerebral Vasoreactivity
- •24.4 TCD/TCCS: Intraoperative Monitoring
- •24.7 Conclusion
- •References
- •25.1 Introduction
- •25.4 CAD: Diagnosis
- •25.6 Pupil: Ultrasound Examination
- •25.11 Conclusion
- •Algorithm
- •References
- •26.1 Introduction
- •26.2 Optimal Settings
- •26.2.1 Probe Types
- •26.2.2 Frequencies
- •26.2.3 Focus
- •26.2.4 Depth
- •26.2.5 Pulse Repetition Frequency (PRF)
- •26.2.6 Frame Rate
- •26.2.8 Freeze
- •26.2.9 Cine Loop
- •26.2.10 Smoothing (Interpolation), Interlacing, Correlation
- •26.2.11 Postprocessing
- •26.2.12 Resolution
- •26.2.13 Doppler-Technique
- •26.2.14 PW-Doppler (Pulsed-Wave Doppler)
- •26.2.15 Color Duplex
- •26.3 Indications
- •26.4.1.2 Morphological Differences
- •26.4.1.3 Flow Differences
- •26.4.1.4 Compression
- •26.5 B-Mode Examination
- •26.5.1 Dilation
- •26.5.2 Intima-Media Thickness (IMT)
- •26.5.3 Plaque Analysis
- •26.5.3.1 Location
- •26.5.3.3 Maximal Thickness
- •26.5.3.4 Surface
- •26.5.3.5 Echogenicity
- •26.5.4 B-Flow Imaging
- •26.6.1 Color Doppler Imaging (CDI)
- •26.6.2 Power Doppler Imaging (PDI)
- •26.7.1 Stenosis Measurement
- •26.7.1.1 Diameter Stenosis
- •26.7.1.2 Area Stenosis
- •26.7.1.3 Residual Luminal Diameter
- •26.7.2 Occlusion
- •26.7.3 Subtotal Stenosis: (>95% Stenosis)
- •26.7.4 Long Segment Stenosis
- •26.8 Doppler Spectrum
- •26.10 Contrast Enhanced Ultrasound (CEU)
- •26.11.1 Common Carotid Artery
- •26.11.2 Internal Carotid Artery
- •26.11.2.1 Stenosis
- •26.11.2.2 Dissection
- •26.11.2.3 Occlusion
- •26.11.2.4 Subtotal Occlusion: (95–99% Stenosis)
- •26.11.2.5 Multiple (Tandem) Stenosis
- •26.11.2.6 Long Segment Stenosis
- •26.11.3 External Carotid Artery (ECA)
- •26.11.3.1 Occlusion
- •26.13 Negative Report
- •26.14 Conclusion
- •Algorithm
- •References
- •27.1 Introduction
- •27.2 Anatomy: Vertebrobasilar System
- •27.3 Vertebrobasilar Circulation: Ultrasound Examination
- •27.4 TCD: Aneurysmal Subarachnoid Hemorrhage
- •27.4.1 Delayed Cerebral Ischemia
- •27.4.2 Vasospasm
- •27.5 TCD: Vertebrobasilar Dissection
- •27.6 TCD: Intracranial Stenosis
- •27.7 TCD: Microembolus Detection
- •27.9 Subclavian Steal Syndrome
- •27.10 TCD: Multimodal Monitoring
- •27.11 TCD: Traumatic Brain Injury
- •27.12 TCD: Brain Death Determination
- •27.13 Conclusion
- •References
- •28.1 Introduction
- •28.2 Cerebral Venous System: Anatomy
- •28.3 vTCCS: Ultrasound Investigation Technique
- •28.4 CVST: Venous Ultrasound Findings

326
D. J. Kutsogiannis
18.3.3.3 Intraparenchymal Cerebral Oxygen Monitoring
Although the fourth edition of the Guidelines for the Management of Severe
Traumatic Brain Injury does not provide guidance for the use of PbtO2 to monitor
patients with TBI, the International Multidisciplinary Consensus Conference on
Multimodality Monitoring in Neurocritical Care strongly recommends monitoring
brain oxygen in patients with or at risk of cerebral ischemia or hypoxia using PbtO2.
This recommendation was made with a low quality of evidence [6]. However, subsequent to these recommendations, the phase II randomized trial (BOOST II) comparing monitoring TBI patients with ICP plus PbtO2 versus ICP alone has
demonstrated that monitoring with both ICP and PbtO2 reduced the proportion of
time with brain tissue hypoxia after severe TBI by more than 50% to only 16% of
the time, and with a trend to lower mortality and more favorable neurological outcomes [47].
18.3.3.4 Cerebral Blood Flow
A recent systematic review has collectively identied SAH, IVH, a low admission
glasgow coma scale (GCS), and age less than 30years as independent predictors of
developing TBI- induced vasospasm [48]. Separate TCD indexes describing cerebral
hypoperfusion or vasospasm both predicted poor outcomes in severe TBI [49]. The
use of TCD/TCCS has also emerged as an important technique to monitor patients
with blunt cerebrovascular trauma or dissection. Transcranial ultrasound microemboli detection has demonstrated a strong association between the number of microemboli per hour and daily persistence of microemboli with the development of
stroke in patients with blunt cerebrovascular injuries [50].
18.3.3.5 Electrophysiology
The current recommendations from the neurointensive care section of the ESICM
for the use of EEG in TBI include (1) a strong recommendation for its use in all TBI
patients with unexplained and persistent altered consciousness and (2) a suggestion
for the use of EEG to exclude NCSz in patients with TBI and GCS<8, especially
in those with large cortical contusions/hematoma, depressed skull fracture, or penetrating injury [22]. As well the prospect for the future use of cortical depth electrodes to monitor for spreading depolarizations as a surrogate for metabolic failure
and excitotoxic injury has recently l
ed to a consensus statement outlining standards
for their recording, analysis, and interpretation [2].

18 Non-invasive Multimodal Neuromonitoring in the ICU: The Role of Transcranial…
327
18.3.3.6 Cerebral Metabolism
The recommended location for microdialysis placement in TBI patients is the nondominant frontal lobe in patients with diffuse TBI and within radiographically normal brain ipsilateral to a focal lesion in focal TBI.The measurement of glucose,
lactate, and lactate–pyruvate (LP) ratio is recommended [29]. Periods of low brain
glucose (<0.8mmol/L) are associated with poor outcomes. An elevated LP ratio in
the presence of low pyruvate and low PbtO2 indicates ischemia, whereas an increase
in the LP ratio with a high pyruvate and normal PbtO2 indicates mitochondrial dysfunction. A rise in LP ratio concomitant with a fall in CPP and a loss of cerebrovascular reactivity (PRx) corresponds to ischemia as the likely etiology. Cerebral
perfusion pressure augmentation, increasing PaCO2, increasing inspired oxygen, or
treating anemia should be considered [5, 29]. Nonischemic metabolic crises appear
to be responsible for most of the incidents of LP elevation and are thought to be
related to mitochondrial dysfunction and reduced oxidative metabolism [51]. The
Consensus Statement from the 2014 International Microdialysis Forum described
cerebral microdialysis to be a reliable and safe technique for the clinical management of TBI or SAH patients [29]. It includes reference values for commonly measured substrates and ranks them based on quantity and usefulness of clinical data,
with glucose and lactate/pyruvate ratio (LPR) being at the top, followed by glutamate and then glycerol. Moreover, when using cerebral microdialysis, one must be
aware of the location of the catheter (peri-contusional versus normal brain) as
results vary widely [52].
18.3.4 Acute Ischemic Stroke (AIS)
18.3.4.1 Cerebral Blood Flow
Flow velocity reduction or occlusion of the MCA in acute ischemic stroke is better
discerned using transcranial color-coded duplex sonography than with standard
TCD methods and the absence of ow reduction/occlusion on TCCS predicted early
clinical improvement [53]. Greater than 30% of patients with successful angiographic recanalization post mechanical thrombectomy for large vessel occlusion
stroke were demonstrated to have abnormally low MCA ow velocities by postintervention TCD.This was dened as thrombosis in brain ischemic grade 0–4. Such
a mismatch between angiographic post-thrombectomy recanalization and poor
TCD ow velocities predicted poor 90-day outcomes [54]. Although TCCS is not
primarily used to direct the decision for angiographic recanalization, consensus recommendations on how to examine intracranial arteries by TCCS in acute ischemic
stroke and its use in monitoring recanalization have been published [55].
More recently, CT perfusion, diffusion-weighted magnetic resonance imaging
(MRI), or MR diffusion/perfusion studies have been recommended in selected patients
with large vessel acute ischemic stroke within 6 to 24hours of last known normal

328
D. J. Kutsogiannis
function to aid in patient selection for mechanical thrombectomy based on the DAWN
and DEFUSE 3 trial [56–58]. These imaging methods dene an initial infarct volume
(ischemic core) and volume of potentially reversible ischemia (penumbra) for the selection of patients for which thrombolytics and thrombectomy are useful. The requirement
for these measurements currently limits the use of TCD/TCCS in this setting.
18.3.4.2 Electrophysiology
Quantitative EEG (QEEG) specically using the delta/alpha power ratio (DAR) has
demonstrated good accuracy in classifying patients with acute ischemic stroke [59].
The DAR, relative alpha power, and national institute of health stroke scale (NIHSS)
score were independent predictors of worsening 30-day NIHSS score in ischemic
cortical stroke patients.
18.3.5 Meningitis andEncephalitis
18.3.5.1 Cerebral Blood Flow
Although there has been a limited description of signicant cerebral blood ow
abnormalities in cases of encephalitis, signicant cerebrovascular abnormalities
have been more notable in meningitis [60]. By varying mean arterial pressure
(MAP) and measuring MCA MFV and jugular oxygen saturation, autoregulation
was found to be impaired but temporarily recovered with hyperventilation in a
series of patients with acute bacterial meningitis. Outcomes were good for those
patients who recovered cerebral autoregulation; however, those who did not, either
died or had a protracted hospital course [61, 62]. Three phases of tuberculous meningitis have been described with progressively worsening outcomes. The rst phase
includes patients with focal reversible neurological decits and a GCS of 15 who
have increased MCA ow velocities (MFV) and normal or slightly decreased
PI.The second phase characterizes patients with focal neurological decits, a GCS
12–14, and decreased MCA MFV and PI.The third phase characterizes patients
with GCS less than 12, severely reduced or absent MCA MFV, and severely reduced
PI.Phase II and III patients have cerebral CT evidence of inammatory meningitis
and infarction with clinical ndings of permanent neurological dysfunction or death
[63]. Disturbed cerebral hemodynamics including MCA stenosis and an increased
PI has been shown using TCCS in a small series of patients with non-HIV cryptococcal meningitis. Good concordance between the TCCS ndings and those seen on
MR angiography was not evident; however, the small number of study patients limits conclusions [64]. The same investigators have demonstrated in a small series of
patients with tuberculous or cryptococcal meningitis that the presence of unilateral
or bilateral MCA stenosis seen on TCCS was associated with 5.3 odds of a poor
outcome (Barthel Index <12) at 6months [65].

18 Non-invasive Multimodal Neuromonitoring in the ICU: The Role of Transcranial…
329
18.4 Conclusion
All current and evolving MMM technologies provide complementary information
for caring for patients in the neurointensive care unit with acute cerebral injuries of
various etiologies. Given the resources required to have these technologies available
within neurointensive care units and to maintain the necessary skills required to
interpret information from these technologies, appropriately designed cohort studies and clinical trials should inform a high level of evidence for their use in clinical
practice. Other current limitations with the use of MMM are that of real-time data
integration, presentation, and analysis. Several sophisticated methods of data analysis such as hierarchical cluster analysis are utilizing physiological data from critically ill patients to formulate patterns predictive of various outcomes. It is hoped
that implementing these intelligent systems in the future will aid in effecting treatment decisions within the neurocritical care unit [66].
References
1. Macdonald RL.Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev
Neurol. 2014;10(1):44–58.
2. Dreier JP, Fabricius M, Ayata C, Sakowitz OW, Shuttleworth CW, Dohmen C, et al.
Recording, analysis, and interpretation of spreading depolarizations in neurointensive care:
review and recommendations of the COSBID research group. J Cereb Blood Flow Metab.
2017;37(5):1595–625.
3. O'Reilly C, Totten AM, Carney N, Tasker RC, Wilberger J, Wright DW, etal. Guidelines for the
management of severe traumatic brain injury, Fourth Edition. Neurosurgery. 2016;80(1):6–15.
4. Czosnyka M, Miller C. Monitoring of cerebral autoregulation. Neurocrit Care.
2014;21(2):95–102.
5. Lazaridis C, Andrews CM.Brain tissue oxygenation, lactate-pyruvate ratio, and cerebrovas-
cular pressure reactivity monitoring in severe traumatic brain injury: systematic review and
viewpoint. Neurocrit Care. 2014;2:345.
6. Le Roux P, Menon DK, Citerio G, Vespa P, Bader MK, Brophy G, etal. The international
multidisciplinary consensus conference on multimodality monitoring in Neurocritical care:
evidentiary tables: a statement for healthcare professionals from the Neurocritical care society and the European Society of Intensive Care Medicine. Neurocrit Care. 2014;21(Suppl
2):S297–361.
7. Holger SJ, Guyatt G, Oxman A.Handbook for grading the quality of evidence and the strength
of recommendations using the GRADE approach. GRADE Handbook Updated. GRADE
working group, October 2013. (gradeworkinggroup.org).
8. Rochwerg B, Alhazzani W, Jaeschke R.Clinical meaning of the GRADE rules. Intensive Care
Med. 2014;40(6):877–9.
9. Jaeschke R, Guyatt GH, Dellinger P, Schünemann H, Levy MM, Kunz R, et al. Use of
GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive.
BMJ. 2008;337:a744.
10. Otite F, Mink S, Tan CO, Puri A, Zamani AA, Mehregan A, etal. Impaired cerebral autoregula-
tion is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage.
Stroke. 2014;45(3):677–82.

330
11. Budohoski KP, Czosnyka M, Smielewski P, Kasprowicz M, Helmy A, Bulters D, et al.
Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid
hemorrhage: a prospective observational study. Stroke. 2012;43(12):3230–7.
12. Calviere L, Nasr N, Arnaud C, Czosnyka M, Viguier A, Tissot B, etal. Prediction of delayed
cerebral ischemia after subarachnoid hemorrhage using cerebral blood ow velocities and
cerebral autoregulation assessment. Neurocrit Care. 2015;23(2):253–8.
13. Ramakrishna R, Stiefel M, Udoteuk J, Spiotta A, Levine JM, Kofke WA, etal. Brain oxy-
gen tension and outcome in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg.
2008;109(6):1075.
14. Ulrich CT, Fung C, Vatter H, Setzer M, Gueresir E, Seifert V, etal. Occurrence of vasospasm
and infarction in relation to a focal monitoring sensor in patients after SAH: placing a bet when
placing a probe? PLoS One. 2013;8(5):e62754.
15. Engquist H, Rostami E, Enblad P.Temporal dynamics of cerebral blood ow during the acute
course of severe subarachnoid hemorrhage studied by bedside xenon-enhanced CT.Neurocrit
Care. 2019;30(2):280–90.
16. Schubert GA, Seiz M, Hegewald AA, Manville J, Thomé C.Acute Hypoperfusion immedi-
ately after subarachnoid hemorrhage: a xenon contrast-enhanced CT study. J Neurotrauma.
2009;26(12):2225–31.
17. Sundt TM Jr, Sharbrough FW, Piepgras DG, Kearns TP, Messick JM Jr, O’Fallon
WM.Correlation of cerebral blood ow and electroencephalographic changes during carotid
endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin
Proc. 1981;56(9):533–43.
18. Jordan KG.Emergency EEG and continuous EEG monitoring in acute ischemic stroke. J Clin
Neurophysiol. 2004;21(5):341–52.
19. Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM. Role of transcranial
Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage.
Neurosurgery. 1999;44(6):1237–47. discussion 47–8
20. Kumar G, Dumitrascu OM, Chiang C-C, O’Carroll CB, Alexandrov AV. Prediction of
delayed cerebral ischemia with cerebral angiography: a Meta-analysis. Neurocrit Care.
2019;30(1):62–71.
21. Kondziella D, Friberg CK, Wellwood I, Reiffurth C, Fabricius M, Dreier JP.Continuous EEG
monitoring in aneurysmal subarachnoid hemorrhage: a systematic review. Neurocrit Care.
2015;3:450.
22. Claassen J, Taccone FS, Horn P, Holtkamp M, Stocchetti N, Oddo M.Recommendations on
the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM.Intensive Care Med. 2013;39(8):1337–51.
23. Gollwitzer S, Groemer T, Rampp S, Hagge M, Olmes D, Huttner HB, etal. Early prediction of
delayed cerebral ischemia in subarachnoid hemorrhage based on quantitative EEG: a prospective study in adults. Clin Neurophysiol. 2015;126(8):1514–23.
24. Claassen J, Hirsch LJ, Frontera JA, Fernandez A, Schmidt M, Kapinos G, et al. Prognostic
signicance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care. 2006;4(2):103–12.
25. Bosco E, Marton E, Feletti A, Scarpa B, Longatti P, Zanatta P, etal. Dynamic monitors of brain
function: a new target in neurointensive care unit. Crit Care. 2011;15(4):R170.
26. Skjøth-Rasmussen J, Schulz M, Kristensen SR, Bjerre P. Delayed neurological decits
detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;100(1):8.
27. Oddo M, Levine JM, Frangos S, Maloney-Wilensky E, Carrera E, Daniel RT, etal. Brain lac-
tate metabolism in humans with subarachnoid hemorrhage. Stroke. 2012;43(5):1418–21.
28. Tholance Y, Barcelos GK, Perret-Liaudet A, Omar E, Carrillon R, Grousson S, etal. Placing
intracerebral probes to optimise detection of delayed cerebral ischemia and allow for the prediction of patient outcome in aneurysmal subarachnoid haemorrhage. J Cereb Blood Flow
Metab. 2017;37(8):2820–32.
29. Hutchinson PJ, Jalloh I, Helmy A, Carpenter KLH, Rostami E, Bellander B-M, etal. Consensus
statement from the 2014 international microdialysis forum. Intensive Care Med. 2015(9):1517.
D. J. Kutsogiannis

18 Non-invasive Multimodal Neuromonitoring in the ICU: The Role of Transcranial…
30. Hemphill JC, Morabito D, Farrant M, Manley GT.Brain tissue oxygen monitoring in intrace-
rebral hemorrhage. Neurocrit Care. 2005;3(3):260–70.
31. Ko SB, Choi HA, Parikh G, Helbok R, Schmidt JM, Lee K, etal. Multimodality monitoring for
cerebral perfusion pressure optimization in comatose patients with intracerebral hemorrhage.
Stroke. 2011;42(11):3087–92.
32. Diedler J, Santos E, Poli S, Sykora M.Optimal cerebral perfusion pressure in patients with
intracerebral hemorrhage: an observational case series. Crit Care. 2014;18(2):R51.
33. Camps-Renom P, Méndez J, Granell E, Casoni F, Prats-Sánchez L, Martínez-Domeño A, etal.
Transcranial duplex sonography predicts outcome following an intracerebral hemorrhage. Am
J Neuroradiol. 2017;38(8):1543–9.
34. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, etal. Hematoma
growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
Neurology. 2006;66(8):1175–81.
35. Leira R, Dávalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, et al. Early neurologic
deterioration in intracerebral hemorrhage. Predictors and associated factors. Neurology.
2004;63(3):461–7.
36. Pérez ES, Delgado-Mederos R, Rubiera M, Delgado P, Ribó M, Maisterra O, et al.
Transcranial duplex sonography for monitoring Hyperacute intracerebral hemorrhage. Stroke.
2009;40(3):987–90.
37. Ovesen C, Christensen AF, Krieger DW, Rosenbaum S, Havsteen I, Christensen H. Time
course of early postadmission hematoma expansion in spontaneous intracerebral hemorrhage.
Stroke. 2014;45(4):994–9.
38. Al-Shahi Salman R, Frantzias J, Lee RJ, Lyden PD, Battey TWK, Ayres AM, etal. Absolute
risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic
review and meta-analysis of individual patient data. Lancet Neurol. 2018;17(10):885–94.
39. Claassen J, Jetté N, Chum F, Green R, Schmidt M, Choi H, etal. Electrographic seizures and
periodic discharges after intracerebral hemorrhage. Neurology. 2007;69(13):1356–65.
40. Vespa PM, O’Phelan K, Shah M, Mirabelli J, Starkman S, Kidwell C, et al. Acute seizures
after intracerebral hemorrhage. A factor in progressive midline shift and outcome. Neurology.
2003;60(9):1441–6.
41. Bellner J, Romner B, Reinstrup P, Kristiansson K-A, Ryding E, Brandt L. Transcranial
Doppler sonography pulsatility index (PI) reects intracranial pressure (ICP). Surg Neurol.
2004;62(1):45–51.
42. Wang Y, Duan YY, Zhou HY, Yuan LJ, Zhang L, Wang W, etal. Middle cerebral arterial ow
changes on transcranial color and spectral Doppler sonography in patients with increased
intracranial pressure. J Ultrasound Med. 2014;33(12):2131–6.
43. Bouzat P, Almeras L, Manhes P, Sanders L, Levrat A, David J-S, etal. Transcranial Doppler
to predict neurologic outcome after mild to moderate traumatic brain injury. Anesthesiology.
2016;125(2):346–54.
44. Steiner LA, Czosnyka M, Piechnik SK, Smielewski P, Chateld D, Menon DK, etal. Continuous
monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral
perfusion pressure in patients with traumatic brain injury. Crit Care Med. 2002;30(4):733–8.
45. Aries MJ, Czosnyka M, Budohoski KP, Steiner LA, Lavinio A, Kolias AG, etal. Continuous
determination of optimal cerebral perfusion pressure in traumatic brain injury. Crit Care Med.
2012;40(8):2456–63.
46. Zeiler FA, Donnelly J, Calviello L, Smielewski P, Menon DK, Czosnyka M.Pressure auto-
regulation measurement techniques in adult traumatic brain injury, part II: a scoping review of
continuous methods. J Neurotrauma. 2017;34(23):3224–37.
47. Okonkwo DO, Shutter LA, Moore C, Temkin NR, Puccio AM, Madden CJ, etal. Brain oxygen
optimization in severe traumatic brain injury phase-II: a phase II randomized trial. Crit Care
Med. 2017;45(11):1907–14.
48. Al-Mufti F, Amuluru K, Changa A, Lander M, Patel N, Wajswol E, etal. Traumatic brain injury
and intracranial hemorrhage–induced cerebral vasospasm: a systematic review. Neurosurg
Focus. 2017;43(5):E14.
331

332
49. Ziegler D, Cravens G, Poche G, Gandhi R, Tellez M.Use of transcranial Doppler in patients
with severe traumatic brain injuries. J Neurotrauma. 2017;34(1):121–7.
50. Bonow RH, Witt CE, Mosher BP, Mossa-Basha M, Vavilala MS, Rivara FP, etal. Transcranial
Doppler microemboli monitoring for stroke risk stratication in blunt cerebrovascular injury.
Crit Care Med. 2017;45(10):e1011–e7.
51. Vespa P, Bergsneider M, Hattori N, Wu HM, Huang SC, Martin NA, etal. Metabolic crisis
without brain ischemia is common after traumatic brain injury: a combined microdialysis and
positron emission tomography study. J Cereb Blood Flow Metab. 2005;25(6):763–74.
52. Engstrom M, Polito A, Reinstrup P, Romner B, Ryding E, Ungerstedt U, etal. Intracerebral
microdialysis in severe brain trauma: the importance of catheter location. J Neurosurg.
2005;102(3):460–9.
53. Goertler M, Kross R, Baeumer M, Jost S, Grote R, Weber S, etal. Diagnostic impact and
prognostic relevance of early contrast-enhanced transcranial color-coded duplex sonography
in acute stroke. Stroke. 1998;29(5):955–62.
54. Kneihsl M, Niederkorn K, Deutschmann H, Enzinger C, Poltrum B, Horner S, et al.
Abnormal blood ow on transcranial duplex sonography predicts poor outcome after stroke
Thrombectomy. Stroke. 2018;49(11):2780–2.
55. Nedelmann M, Stolz E, Gerriets T, Baumgartner Ralf W, Malferrari G, Seidel G, et al.
Consensus recommendations for transcranial color-coded duplex sonography for the assessment of intracranial arteries in clinical trials on acute stroke. Stroke. 2009;40(10):3238–44.
56. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, etal. 2018
guidelines for the early management of patients with acute Ischemic stroke: a guideline for
healthcare professionals from the American Heart Association/American Stroke Association.
Stroke. 2018;49(3):e46–e110.
57. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, etal. Thrombectomy
6 to 24 hours after stroke with a mismatch between decit and infarct. N Engl J Med.
2018;378(1):11–21.
58. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al.
Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med.
2018;378(8):708–18.
59. Finnigan S, Wong A, Read S.Dening abnormal slow EEG activity in acute ischaemic stroke:
Delta/alpha ratio as an optimal QEEG index. Clin Neurophysiol. 2016;127(2):1452–9.
60. Kargiotis O, Safouris A, Magous G, Stamboulis E, Tsivgoulis G. Transcranial color-
coded duplex in acute encephalitis: current status and future prospects. J Neuroimaging.
2016;26(4):377–82.
61. Moller K, Larsen FS, Qvist J, Wandall JH, Knudsen GM, Gjorup IE, et al. Dependency of
cerebral blood ow on mean arterial pressure in patients with acute bacterial meningitis. Crit
Care Med. 2000;28(4):1027–32.
62. Moller K, Skinhoj P, Knudsen GM, Larsen FS. Effect of short-term hyperventilation on
cerebral blood ow autoregulation in patients with acute bacterial meningitis. Stroke.
2000;31(5):1116–22.
63. Kiliç T, Elmaci I, Özek MM, Pamir NM.Utility of transcranial Doppler ultrasonography in
the diagnosis and follow-up of tuberculous meningitis-related vasculopathy. Childs Nerv Syst.
2002;18(3):142–6.
64. Chang W-N, Lu C-H, Chang H-W, Lui C-C, Tsai N-W, Huang C-R, etal. Time course of
cerebral hemodynamics in cryptococcal meningitis in HIV-negative adults. Eur J Neurol.
2007;14(7):770–6.
65. Lu C-H, Chang W-N, Chang H-W, Chung K-J, Tsai N-W, Lui C-C, etal. Clinical relevance
of intracranial arterial Stenoses in tuberculous and Cryptococcal meningitis. Infection.
2007;35(5):359–63.
66. Cohen MJ, Grossman AD, Morabito D, Knudson MM, Butte AJ, Manley GT.Identication of
complex metabolic states in critically injured patients using bioinformatic cluster analysis. Crit
Care. 2010;14(1):R10.
D. J. Kutsogiannis

Chapter 19
Acute Neurologic Injury inICU:
Vasomotor Reactivity Testing
byTranscranial Doppler (TCD/TCCS)
PedroCastro andElsaAzevedo
Key Points
1. Breath-hold test, carbogen inhalation and acetazolamide are the most commonly
used stimulus.
2. Worse vasoreactivity has been linked to prognosis in critical care patients.
3. Decreased cerebral vasoreactivity increases the risk of cerebral ischemic lesions.
19.1 Introduction
Cerebral vasoreactivity or vasomotor reactivity (VMR) is an index of cerebral blood
ow (CBF) or velocity (CBFV) in response after administration of a vasomodulatory stimulus, whether it is a drug (e.g. acetazolamide intravenous), gases (e.g. carbogen), or a manoeuvre that causes changes in PaCO2 (e.g. apnoea or hyperventilation)
[1]. Important note is that such a denition leaves reactivity to change in cerebral
perfusion pressure (PP) in a chapter related to autoregulation. Vasodilation is most
commonly studied. The aim of VMR or vasomotor evaluation is to measure the
capacity and amplitude of variation of resistance vessel calibre, which for some
P. Castro (*)
Department of Clinical Neurosciences and Mental Health, Faculty of Medicine of University
of Porto, Porto, Portugal
Department of Neurology and Stroke Unit, Centro Hospitalar Universitário de São João,
E.P.E, Porto, Portugal
e-mail: pedromacc@gmail.com
E. Azevedo
Neurologist, Department of Clinical Neurosciences and Mental Health, Faculty of Medicine
of University of Porto, Porto, Portugal
Department of Neurology, Universitary Hospital São João, Porto, Portugal
Committee Member - ESNCH, Oslo, Norway
C. N. Rodríguez et al. (eds.), Neurosonology in Critical Care,
https://doi.org/10.1007/978-3-030-81419-9_19
333© Springer Nature Switzerland AG 2022

334
()
()
84Lr
/^
authors can be understood as “cerebrovascular reserve” [2–4]. Generally, both middle cerebral arteries (MCA) are monitored because they represent a larger brain area
and have reference values in the literature [2]. The VMR to CO2 test is mostly used
in research, while the simpler apnoea test [5] may be more practical in the clinical
setting. Literature is confusing about VMR testing since the term vasomotor is
sometimes used to refer to cerebral autoregulation, which is a different physiological property of cerebral vessels than concerns blood pressure inuences and is measured with different techniques.
P. Castro and E. Azevedo
19.2 Cerebral Blood Haemodynamic Measurements
VMR testing requires measurement of CBF or equivalent. The rst can be assessed
by measuring regional CBF by single-photon emission computed tomography or
positron emission tomography. CBFV is measured by transcranial Doppler (TCD).
The imaging methods have the advantage of spatial discrimination when compared
to TCD but lack time resolution and involve cumbersome, expensive protocols and
irradiation. New methods are being tested with arterial spin labelling magnetic resonance imaging, which can be difcult to put in practice in ICU patients [2]. TCD has
the advantage of being more practical, with bedside testing and monitoring of the
patient through the time course of its condition.
19.3 Cerebral Blood Flow (CBF): Physiology Principles
Blood ow does not follow the simple laws of Newtonian uids and is best studied
by rheological principles [6]. However, in a more simplistic perspective, we can
describe the blood ow by Ohm’s law according to the formula Q = ΔP / R, where
Q represents the ow in ml.min-1, ΔP is the blood pressure gradient, and R is the
vascular resistance. In the case of the brain [7], ΔP is the cerebral PP, the difference
between the mean BP (MAP) and the transmural pressure opposing the ow. In the
systemic circulation, the only contributory and relevant factor for this is the venous
pressure (2–5 mm Hg) [6]. Considering the normal values of peripheral MAP
(≈80mm Hg), we can approximate the formula such that Q ≅ MAP / R for the general peripheral circulation.
The determinants of R are explained by the Hagen–Poiseuille law (Eq.19.1),
where L is the length of the vessel and η is the blood viscosity of the cross-sectional
radius of the vessel [8]. From this, we can see the central importance of resistance
vessels, in which small variations in their diameter exponentially modify the blood
ow in the organ they nourish.
R =×
η
×
Π
(19.1)

40
19 Acute Neurologic Injury in ICU: Vasomotor Reactivity Testing by Transcranial…
335
Despite what has already been said, some precautions are necessary for the CBF
study because intracranial circulation has a special character, in which the perfused
organ is inside a rigid skull bathed in cerebrospinal uid (CSF). Thus, CSF pressure,
that is, intracranial pressure (ICP), which is usually between 0 and 15mm Hg, may
dominate and replace venous pressure in ΔP. In non-invasive conditions, we do not
have access to the value of ICP and it is ignored. However, in certain ICU patients
ICP may reach values higher than 30–40mm Hg and signicantly alter the parameters to be taken into account in the formula. In conclusion, both MAP and ICP
should be kept constant during CO2 challenge since these are factors that altered
per se CBF.
19.4 Vasoreactivity Determining: Methods
There are three main methods for determining VMR:
1. Breath-Hold Test [5]: After a period of rest and a normal inspiration, the indi-
vidual is instructed to remain in apnoea for about 30 seconds (minimum of
24seconds) with consequent increase of PaCO2. A breath-hold index (BHI) is
calculated by using mean CBFV (MFV) values by formula BHI=(MFVmax –
MFVbaseline)/MFVbaseline/apnoea time (in seconds)× 100, where MFVmax
corresponds to the average MFV in the last 4seconds of apnoea and MFVbaseline
to the average values of MFV in the minute preceding apnoea, which requires a
cooperative conscious patients but no capnography. Some authors couple this
manoeuvre with hyperventilation to access global VMR capacity as described
below [1]. Disadvantage is that change in CBFV cannot be compared with
change of PaCO2.
2. CO2 VMR Test [9]: Here, MFV changes are monitored continuously with those
of the EtCO
patients, we can use a mask with non-recirculating circuit coupled to a reservoir
by capnography [Figs. 19.1, 19.2, and 19.3]. In non-intubated
2
CO2 (mmHg) expiratório
0
Fig. 19.1 Capnography nasal line for non-invasive end-tidal CO2 measurement. Normal subject.
After the inspiratory phase (white bar), during which there is no ow in the cannula, the device
detects a sudden increase in carbon dioxide (CO
believed to be in equilibrium with alveolar CO
approaches the real value of arterial PaCO
waveform from sample line in the orotracheal apparatus
) during expiration, leading to a plateau stage
2
partial pressure. Therefore, the end-tidal CO2 level
2
. In intubated patients, capnography produces similar
2
Соседние файлы в папке Библиотека им академика М.И. Перельмана
